Filing Flows › National Health Investors (NHI) › Q3 2026 › vs Q3 2025
National Health Investors (NHI) Q3 2026 vs Q3 2025 (year over year)
National Health Investors's revenue rose $23.6M (+26%) from $89.8M in Q3 2025 to $113M in Q3 2026. Operating margin 495.9% against 36.1% (+459.9 pts).
National Health Investors, Q3 2026: revenue $113M (+26% year over year), operating margin 495.9%, net earnings $564M, operating cash flow $48.0M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Operating margin | 495.9% | 36.1% | +459.9 pts |
| Net margin | 496.6% | 36.6% | +460.0 pts |
| Free cash flow margin | 36.3% | 62.4% | -26.1 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $113M | $89.8M | $23.6M | +26% |
| Operating profit | $563M | $32.4M | $530M | 17× |
| Pre-tax earnings | $563M | $32.4M | $530M | 17× |
| Loss borne by minority interests | $311K | $384K | −$73K | -19% |
| Net earnings | $564M | $32.9M | $531M | 17× |
| Income tax | $279K | $0 | $279K | — |
| Depreciation & amortization | $25.8M | $20.2M | $5.5M | +27% |
| Share-based compensation | $1.5M | $983K | $480K | +49% |
| Working capital & other | $543M | −$8.5M | $551M | — |
| Operating cash flow | $48.0M | $62.5M | −$14.6M | -23% |
| Free cash flow (OCF − capex) | $41.2M | $56.1M | −$14.9M | -27% |
| Capital expenditures | $6.8M | $6.4M | $361K | +6% |
Questions
How much did National Health Investors's revenue grow year over year in Q3 2026?
National Health Investors's revenue rose $23.6M (+26%) from $89.8M in Q3 2025 to $113M in Q3 2026. Operating margin 495.9% against 36.1% (+459.9 pts).